Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Enoxaparin Compared to Unfractionated Heparin for Short Term Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing TEE Guided Cardioversion: Assessment of Cardioversion Using Transesophageal Echocardiography (ACUTE) II Randomized Multicenter Study

NCT00289042 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT00289042
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00289042 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Enoxaparin Compared to Unfractionated Heparin for Short Term Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing TEE Guided Cardioversion: Assessment of Cardioversion Using Transesophageal Echocardiography (ACUTE) II Randomized Multicenter Study
Lead sponsor
The Cleveland Clinic
Phase
Phase 4
Overall status
Completed
Start date
December 31, 1999
Completion date
November 30, 2004
Enrollment
200
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation